Follow the 프리시젼바이오 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 프리시젼바이오 has published 32 public disclosures. The latest transaction was disclosed on 10 February 2026 (Purchase). Among the most active insiders: 아이센스. The full history is free.
32
Insider Decl.
0
Thresholds
·
8 ops.
Buy Volume
·
3 ops.
Sell Volume
11Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.